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The Hippo signaling pathway, a highly conserved pathway between flies and mammals, 
regulates the rate of cell growth and apoptosis to ultimately control organ size and tissue 
homeostasis (Saucedo & Edgar, 2007). The pathway was named after an overgrowth 
phenotype, a fly resembling a hippopotamus, observed in Drosophila upon mutating Hpo 
(Wu et al., 2003). The action of the Hippo pathway arises from the activity of a set of two 
kinases. Mst1/2 kinase phosphorylates and activates Lats1/2 kinase in a process that may 
be stimulated by the effector protein Mob1, which is also a substrate of Mst1/2 (Ni et al., 
2015). This study aims to identify a minimal, functional unit of Lats1 more amenable to 
both purification in vitro and X-ray crystallization. We designed truncations of both the N 
and C-termini of Lats1. We transiently transfected Mst2, Mob1, Lats1, and YAP in 
HEK293 cells and validated kinase activity of the truncated Lats1 variants by Western 
blot and the luciferase reporter assay. We also analyzed complex formation between 
Mob1 and the truncated Lats1 variants using co-immunoprecipitation from lysate of 
HEK293 cells transiently transfected with both proteins. We will purify the minimal, 
functional unit of Lats1 in vitro for use in future biochemical and structural assays. This 
study also aims to understand the molecular role of Mob1 in the activation of Lats1 
kinase. We transiently transfected HEK293 cells with Mst2 and Lats1 with or without 
Mob1 and monitored Lats1 activation by Western blot. Expression of Mob1 stimulated 
phosphorylation of Lats1 by Mst2, highlighting a potential role for Mob1 in Lats1 
activation and ternary complex formation between Lats1, Mob1, and Mst2. We aim to 
isolate the ternary complex in vitro and test the phosphospecific nature of assembly of the 
ternary complex. We will also determine the sequence of molecular events that lead to 
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Lats1 activation by systematically disrupting pairwise interactions between either Mst2 
and Mob1 or Lats1 and Mob1 and monitor the effect on Lats1 activation in cells. Several 
studies have identified mutations in human cancers that affect Lats1/2 expression and 
kinase activity (Yu, Bachman & Lai, 2013). Thus, the results of this study will provide 
insight into the mechanisms that regulate Lats1 activation and provide a framework to 





















Advisor: Jennifer M. Kavran, Ph.D. 
 





First, I would like to thank Dr. Jennifer M. Kavran, my advisor and mentor during 
these past two years. I feel incredibly lucky to have met her. I have asked more questions, 
thought more critically, and felt more motivated because of her invaluable mentorship 
and unending patience. I aspire to share her enthusiasm and passion for scientific research 
throughout my career.  
I would like to thank Dr. Floyd Bryant. His mentorship during my first year of 
this program gave me the confidence to pursue a Master of Science, and he has 
continuously supported me with every step of this experience. I would also like to thank 
Dr. Anthony Leung for his advice with this manuscript. 
I would like to recognize the members of the Kavran Lab. I want to thank Dr. 
Thao Tran. Thao helped me to pursue my interests and was always eager to answer my 
questions, even those asked at odd hours of the night. I want to recognize Leah Cairns 
and Thomas Koehler for their help with this manuscript. Also, their friendship and 
support have been invaluable throughout my time at the Kavran Lab. I would also like to 
recognize Brendan Fowl for his help with the identification of the minimal, functional 
unit of Lats1 kinase and his completion of the luciferase assay. 
Finally, I would like to thank my friends and family. I would like to acknowledge 
Alisa Boyko. She has inspired me to emulate her incredible passion for scientific research 
and the warmth and care she shares with others. I want to thank Stephen Reginald 
Wellard for the encouragement he shared and his tireless effort editing this manuscript. 
Most importantly, I would like to recognize my mother, Hee Jung Kim, and father, Yong 
Ha Kim. They are my role models, and their dedication and passion to both their work 
 
 v 









List of Tables ............................................................................................................... vii
List of Figures............................................................................................................. viii
Chapter 1: Introduction ................................................................................................ 1
Chapter 2: Defining the minimal, functional unit of Lats1 kinase .............................. 5
Introduction ................................................................................................................. 5
Materials and Methods ................................................................................................ 9
Results ...................................................................................................................... 13
Discussion ................................................................................................................. 23
Chapter 3: The molecular role of Mob1 in the activation of Lats1 kinase................ 25
Introduction ............................................................................................................... 25
Materials and Methods .............................................................................................. 32
Results ...................................................................................................................... 36
Discussion ................................................................................................................. 49
Chapter 4: Co-immunoprecipitation to capture and analyze protein:protein 
complexes ..................................................................................................................... 51
Introduction ............................................................................................................... 51
Materials and Methods .............................................................................................. 54
Results ...................................................................................................................... 57
Discussion ................................................................................................................. 62
Chapter 5: Purification of Protein G’ for use in co-immunoprecipitation ............... 64
Introduction ............................................................................................................... 64
Materials and Methods .............................................................................................. 66
Results ...................................................................................................................... 71
Discussion ................................................................................................................. 83
Chapter 6: Conclusion ................................................................................................ 85
References.................................................................................................................... 88




List of Tables  
 













































































List of Figures  
 




Figure 1.2: Schematic of Hippo pathway core kinase cassette 
 
4 
Figure 2.1: Structure and activation of Lats1 kinase  
 
6 




Figure 2.3: Testing complex formation between Lats1 truncated variants 
and Mob1 using co-immunoprecipitation 
 
18 
Figure 2.4: Analysis of substrate phosphorylation by truncated Lats1 
variants using Western blot 
 
20 
Figure 3.1: Mob1 N-terminal extension undergoes conformational change 
when phosphorylated by Mst2 
 
26 




Figure 3.3: Pull-down of Lats1-Mob1-Mst2 ternary complex in vitro 
 
38 
Figure 3.4: Methods to increase the solubility and expression of Lats1 
Mob1 binding domain  
 
39 
Figure 3.5: Limited binding of Lats1 Mob1 binding domain to the cation 
exchange chromatography column at 100mM NaCl  
 
41 
Figure 3.6: Lats1 Mob1 binding domain binds the cation exchange 
chromatography column at 50mM NaCl 
 
42 
Figure 3.7: Lats1 Mob1 binding domain interacts with the gel filtration 
chromatography column   
 
45 
Figure 3.8: Increasing NaCl concentration minimizes Lats1 Mob1 binding 




Figure 3.9: Increasing NaCl concentration does not disrupt the interaction 





Figure 3.10: Substituting gel filtration chromatography with cation 
exchange chromatography results in complete isolation of Lats1 Mob1 
binding domain  
 
48 
Figure 4.1: Schematic of immunoprecipitation of protein complexes 
 
52 
Figure 4.2: Lysis buffer may disrupt protein:protein interactions 
 
58 




Figure 4.4: Increasing the detection of Lats1 and Mob1 protein complex  
 
61 
Figure 5.1: Small-scale Protein G’ expression and solubility tests  
 
72 
Figure 5.2: IMAC Purification of H6SUMO-Protein G’ 
 
74 








Figure 5.5: Purification of Protein G’ expressed as untagged Protein G’ 
using anion exchange chromatography 
 
78 












Yes-associated Protein (YAP) was identified as the downstream target of Hippo 
signaling (Hao et al., 2008). YAP is a transcription-factor that associates with TEA-
domain (TEAD) transcription factor in the nucleus to stimulate the expression of genes 
related to cell proliferation (Hao et al., 2008; Zhao et al., 2008). Hippo signaling 
regulates the localization of YAP to depress proliferative signals and promote apoptosis 
(Hao et al., 2008). 
Since the discovery of the key Hippo pathway components, many studies have 
provided insight into the interactions that mediate Hippo signaling. The Hippo pathway 
core kinase cassette is shown in Figure 1.2. Mammalian sterile20 like kinase (Mst1/2) is 
a serine/threonine kinase. Mst1/2 phosphorylates both Mob, a co-activator, and Large 
tumor suppressor (Lats1/2) kinase (Chan et al., 2005; Praskova et al., 2008). Mst1/2 
phosphorylates Lats1/2 kinase, and this modification is necessary for Lats1/2 kinase 
activation (Chan et al., 2005). Mob1 binds Lats1/2 and stimulates Lats1/2 kinase activity 
(Hergovich, Schmitz & Hemmings, 2006). Activated Lats1/2 kinase phosphorylates YAP 
at residue S127 resulting in sequestration of YAP from the nucleus (Hao et al., 2008). 
Flies expressing mutant YAP S127A display an overgrowth phenotype (Dong et al., 
2007). This result further validates the importance of Hippo signaling in regulating tissue 
homeostasis through inhibitory phosphorylation of YAP.  
Aberrant Hippo signaling, such as increased YAP expression and deactivation or 
loss of Lats1/2, have been identified in many different human cancers (Halder & 
Johnson, 2010). Not only has Hippo signaling been associated with tumorigenesis but 
recent studies have also identified a possible role of Hippo signaling in tissue 
regeneration (Halder & Johnson, 2010). Following partial hepatectomy in rats, YAP 
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protein level increases in the liver (Wang et al., 2011). Also, the overgrowth phenotype 
caused by YAP overexpression in mice liver can be reversed by silencing YAP 
overexpression (Camargo et al., 2007; Dong et al., 2007). In humans, Hippo signaling 
changes in response to liver damage as detected by YAP localization to the nucleus (Bai 
et al., 2012). Thus, the applications of the Hippo pathway are vast, ranging from the 
development of therapeutic targets to combat tumorigenesis and use in tissue 
regeneration following injury. 
Here, we are interested in the molecular mechanism for Lats1/2 kinase activation. 
Lats1/2 kinase phosphorylates YAP to sequester YAP, the downstream target of Hippo 
signaling, from the nucleus. First, we aim to define a minimal, functional unit of Lats1 
kinase for use in future biochemical and structural assays. Much of the N and C-termini 
of Lats1/2 is disordered that is problematic for X-ray crystallization. Next, we aim to 
elucidate the molecular role of Mob1 in the activation of Lats1 kinase. Mob1 associates 
with both Mst2 and Lats1, the two key kinases of the Hippo pathway core kinase cassette. 
By elucidating the role that Mob1 plays in Hippo signaling, we will better understand the 




Defining the minimal, functional unit of Lats1 kinase 
Introduction 
The Hippo pathway controls cell proliferation through cytoplasmic sequestration 
of the transcriptional coactivator YAP (Hao et al., 2008). Lats1/2, a key kinase in the core 
kinase cassette of the Hippo pathway, is responsible for the phosphorylation of YAP that 
prevents nuclear translocation (Hao et al., 2008). Despite the roles that Lats1/2 has been 
shown to play in tumorigenesis and cell cycle regulation, our understanding of the 
structure and function of Lats1/2 kinase is limited. 
Lats1/2 kinase is part of the LATS/NDR (Nuclear dbf2-Related) kinase family, a 
subclass of the AGC serine/threonine kinase superfamily (Tamaskovic et al., 2003). AGC 
kinases are named after cAMP-dependent protein kinase 1 (PKA), cGMP-dependent 
protein kinase (PKG), and protein kinase C (PKC). AGC kinases share sequence 
similarity within the kinase domain (Pearce et al., 2010). The kinase domain takes the 
shape of a bilobal kinase fold: a smaller lobe that is N-terminal and a larger C-terminal 
lobe. Two other regions are also conserved amongst most AGC kinases: the activation 
loop within the kinase domain and the hydrophobic motif, which lies C-terminal to the 
kinase domain (Figure 2.1). Most AGC kinases also share a mechanism for kinase 
activation. Phosphorylation of two conserved regions, the activation loop and 




Mst1/2 phosphorylation of the hydrophobic motif triggers Lats1/2 autophosphorylation of 
the activation loop (Chan et al., 2005). Multiple studies have demonstrated that 
phosphorylation of the hydrophobic motif and activation loop are necessary for Lats1/2 
kinase activity (Chan et al., 2005; Hergovich, Schmitz & Hemmings, 2006; Hoa et al., 
2016).   
A hallmark of NDR kinases is an interaction with an allosteric activator from the 
Mob family of proteins. N-terminal to the kinase domain, each NDR kinase has a 
conserved Mob binding domain (MBD). However not all Mob proteins bind all NDR 
family kinases (Bichsel et al., 2004; Devroe et al., 2004; Kohler et al., 2010). Only Mob1 
binds Lats1/2, and binding between Lats1/2 and Mob1 stimulates Lats1/2 
autophosphorylation and substrate phosphorylation. The interaction between Mob1 and 
Lats1/2 is also observed in the Drosophila homologs – binding between Mats and Warts 
stimulates Warts kinase activity (Wei, Shimizu & Lai, 2007; Vrabioiu & Struhl, 2015). 
Mutational analysis further confirms the importance of Mob1 binding to Lats1/2. If the 
Mob1 and Lats1/2 binding interaction is inhibited, autophosphorylation and substrate 
phosphorylation by Lats1/2 significantly decreases compared to wild-type (wt) Lats1/2 
(Hergovich, Schmitz & Hemmings, 2006; Ni et al., 2015; Hoa et al., 2016). In summary, 
three components are critical for Lats1/2 kinase activation: phosphorylation of the 
hydrophobic motif by Mst1/2, autophosphorylation of the activation loop, and binding to 
Mob1, a co-activator (Figure 2.1). 
A long-term goal of this project is to determine the minimal, functional unit of 
Lats1 for use in biochemical and structural studies. Lats1 has a 712 amino acid long N-
terminal region. The majority of the N-terminal region is predicted to be disordered by 
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secondary structure predictions and is not conserved between Lats1/2 homologs (Figure 
2.2). Currently, the available structural data of Lats1 is limited to the MBD. Ni et al. 
resolved residues 602 – 703, and Kim et al. resolved residues 621 – 703 within the MBD 
(Ni et al., 2015; Kim et al., 2016). Thus, the reason to determine a minimal variant of 
Lats1 is that full-length Lats1 (127kDa) has proven technically challenging to express 
and purify in vitro. We also identified four functions that a minimal Lats1 needs to 
maintain based on available cellular and genetic data: hydrophobic motif 
phosphorylation, autophosphorylation of its activation loop, binding to a co-activator, 





Materials and Methods 
Cloning of Lats1 variants 
The N-terminal truncated, C-terminal truncated, and kinase-dead (kd) (D827N) Lats1 
variants were cloned using standard mutagenesis in pcDNA-3.1/3XMyc-Lats1 (Addgene) 
(Table 2.6). All variants were confirmed by DNA sequencing.  
 
Sequence and structural analysis 
Clustal Omega was used to perform sequence alignments between Lats1, Lats2, and 
Warts (Slevers et al., 2011). Secondary structure of Lats1 was predicted using JPred4 
(Alexey Drozdetskiy et al., 2015). 
 
Transient transfection of HEK293 cells 
HEK293T cells were cultured in DMEM medium (Gibco) supplemented with 5% 
FBEssence (VWR) and 2mM Glutamine (Thermo Fischer) and grown at 37  and 5% 
CO2. HEK293T cells were seeded and transiently transfected one day later using 
polyethylenimine hydrochloride transfection reagent (PEI Max, Polysciences Inc.) at a 
ratio of 3 l of PEI Max to 1 g of DNA. Seeding densities are reported in Table 2.1. The 
pcDNA plasmids transfected are indicated in Table 2.2 and Table 2.3. 48 hours after 
transfection, cell medium was aspirated, and cells were washed with 1mL ice-cold 
phosphate-buffered saline (PBS). PBS was aspirated, and cells were incubated with ice-
cold immunoprecipitation buffer (IP buffer) (20mM Tris pH 8.0, 150mM NaCl, 1% 
Nonidet P-40 (NP-40), and 10% glycerol) supplemented with 50mM NaF, 1mM Na3VO4, 








Designing Lats1 truncated variants  
We used secondary structure predictions, sequence conservation, and structural 
information to design a series of Lats1 variants with truncated N-termini. Most of the N-
terminal region of Lats1 is predicted to be disordered by secondary structure predictions, 
and between Lats1 homologs, there is minimal sequence conservation (Figure 2.2A). 
Two X-ray structures of Mob1 bound to the MBD of Lats1 revealed that the MBD went 
from disordered to ordered at residues 635-638 (Ni et al., 2015; Kim et al., 2016). The 
structures match secondary sequence predictions as -helix formation is predicted to start 
at residue 636. Using these constraints, we designed a series of Lats1 variants with 
truncated N-termini that should maintain binding to Mob1 and kinase activity (Table 
2.6).  
We designed five Lats1 variants with N-terminal truncations (Table 2.6). Two 
began with the residues that were purified for crystallization in the structures of Lats1 
MBD bound to Mob1, 603 and 622 (Ni et al., 2015; Kim et al., 2016). The variant 
starting at residue 612 spanned the two starts of the Lats1 MBD purified for 
crystallization (Ni et al., 2015; Kim et al., 2016). The variant starting at 635 represented 
Lats1 MBD that maintains ordered secondary structure in both secondary sequence 
predictions and the two crystal structures of Lats1 MBD bound to Mob1. Last, we made a 
Lats1 variant that lacked the entire MBD to use as a negative control; the variant started 
at 713. Here, the Lats1 variants with truncated N-termini will be referred to by their 
starting residue with the Kavran Lab plasmid code indicated in brackets. 
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We used the same techniques to design a series of Lats1 variants with truncated 
C-termini. The hydrophobic motif within the C-terminus is highly conserved within not 
only LATS/NDR kinases but also the AGC kinase family (Pearce et al., 2010). Other 
than the hydrophobic motif, which is predicted to form a -strand, most of the region C-
terminal to the kinase domain is predicted to be disordered by secondary structure 
predictions. Also, between Lats1/2 homologs, there is minimal sequence conservation 
within the region C-terminal to the kinase domain (Figure 2.2B).  
We designed six Lats1 variants with C-terminal truncations (Table 2.6). We made 
a Lats1 variant that ended at residue 1078, thus lacking T1079 to serve as a negative 
control when detecting kinase activity. Residue T1079 is necessary for Lats1 kinase 
activation (Chan et al., 2005). The variant terminating at residue 1085 conserves the C-
terminal region until the end of the hydrophobic motif. The last four variants (terminating 
at residues 1092, 1100, 1109, and 1119) were designed to terminate further along the C-
terminal tail where there is minimal sequence conservation and no predicted secondary 
structure. Here, the Lats1 variants with truncated C-termini will be referred to by their 













Validation of the minimal functional unit of Lats1  
We planned to validate the function of the truncated Lats1 variants using three 
criteria. First, binding to Mob1 stimulates Lats1 substrate phosphorylation and 
autophosphorylation (Chan et al., 2005). We conducted a series of co-
immunoprecipitations in HEK293 cells to examine complex formation between the Lats1 
variants and Mob1. Second, Lats1 kinase is crucial for Hippo signaling as it mediates 
phosphorylation of YAP, the downstream target of Hippo signaling (Hao et al., 2008). 
We analyzed Lats1 kinase activity using two different experiments. HEK293 cells were 
transiently transfected with Mst2, Lats1, Mob1, and YAP. Phosphorylation of YAP was 
detected using Western blot analysis. Also, the luciferase reporter assay, which detects 
downstream Hippo pathway signaling, was used to compare kinase activity of the 
truncated Lats1 variants and wt Lats1. Third, Lats1 kinase activation requires 
phosphorylation of the hydrophobic motif by Mst2 and subsequent autophosphorylation 
of the activation loop (Chan et al., 2005). We aimed to transiently transfect HEK293 cells 
with the Lats1 variants, Mst2, and Mob1 and analyze the phosphorylation of those two 
residues using Western blot analysis. 
 
Detecting complex formation of Lats1 and Mob1 in HEK293 cells 
Truncated Lats1 variants and Mob1 were co-immunoprecipitated in HEK293 cells 
to analyze complex formation (Figure 2.3). As predicted, 713 [FZ] did not bind Mob1. 
622 [GN] was the smallest Lats1 variant that bound Mob1 comparable to wt Lats1. Only 




Analyzing substrate phosphorylation by truncated Lats1 kinase variants 
We compared kinase activity of wt Lats1 and Lats1 truncated variants by 
detecting substrate phosphorylation using Western blot analysis. Mst2, Mob1, YAP, and 
Lats1 were transiently transfected into HEK293 cells, and phosphorylation of YAP was 
detected using Western blot analysis (Figure 2.4). We predicted that 1078 [HE] would 
not phosphorylate YAP as T1079, phosphorylation of which is necessary for Lats1 kinase 
activation, was truncated. We did not detect a discrete band to indicate phosphorylation 
of YAP by both 1078 [HE] and kd Lats1. We also detected minimal substrate 
phosphorylation by 713 [FZ] compared to wt Lats1. All other Lats1 truncated variants 





Transient transfection of truncated Lats1 variants affect Hippo pathway function 
Brendan Fowl conducted luciferase reporter assays in HEK293 cells to test Lats1 
kinase activity as detected by Hippo pathway function (Figure 2.5). YAP 
phosphorylation by Lats1 kinase sequesters the transcriptional co-activator from the 
nucleus. Expression of luciferase indicates YAP localization to the nucleus. Thus, a 
decrease in luciferase expression is dependent upon phosphorylation of YAP and 
subsequent inhibition of YAP transcriptional co-activity. Transient transfection of the 
two variants that we designed to serve as negative controls for the phosphorylation of 
hydrophobic motif and Mob1 binding, 1078 [HE] and 713 [FZ] respectively, resulted in 
significantly increased activity status of YAP from wt Lats1. Transient transfection of all 
other Lats1 variants resulted in an insignificant change in luciferase activity when 






In the Kavran Lab, our goal is to purify Lats1 kinase and resolve the structure of 
Lats1 kinase using X-ray crystallography. Here, we aimed to isolate a minimal, 
functional unit of Lats1 that would maintain phosphorylation of the hydrophobic motif by 
Mst2, autophosphorylation of the activation loop, binding to Mob1, and substrate 
phosphorylation comparable to wt Lats1. We designed truncations of the N and C-termini 
of Lats1 to minimize the predicted disordered regions and experiments to validate the 
function of the truncated Lats1 variants. Thus far, we have isolated sections of the N and 
C-termini of Lats1 that preserve Lats1 binding to Mob1 and mediate comparable 
substrate phosphorylation and pathway function as wt Lats1.  
We used secondary structure predictions and sequence conservation to design the 
N-terminal and C-terminal truncations of Lats1 (Figure 2.1). We also referred to 
previous structural analysis of Lats1 MBD to design N-terminal truncations of Lats1 that 
would mediate binding of Lats1 to Mob1 (Ni et al., 2015; Kim et al., 2016). The smallest 
Lats1 N-terminal truncated variant that binds Mob1 and maintains comparable kinase 
activity as wt Lats1 is 622 [GN], which encompasses the MBD purified by Kim et al. 
(Kim et al., 2016). The smallest Lats1 C-terminal truncated variant that binds Mob1 and 
maintains comparable kinase activity as wt Lats1 is 1085 [HB] that preserves the 
hydrophobic motif within the C-terminal tail.  
We predicted that truncated Lats1 variants that cannot bind Mob1 would also 
have decreased kinase activity compared to wt Lats1 as Mob1 binding stimulates 
substrate phosphorylation by Lats1 (Chan et al., 2005). Although we did not detect 
complex formation between 635 [GJ] and Mob1, 635 [GJ] had comparable kinase 
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activity to wt Lats1 analyzed by substrate phosphorylation and pathway function. We 
knew that we could detect changes in Lats1 kinase activity resulting from inhibition of 
Lats1 binding to Mob1 as 713 [FZ] showed a significant difference in both pathway 
function and substrate phosphorylation when compared to wt Lats1. The difference in 
results on the function of 635 [GJ] may be attributed to decreased expression. 
Immunoblots of cell lysate from the co-immunoprecipitation and substrate 
phosphorylation experiments showed decreased 635 [GJ] expression that may have 
affected the capture of the 635 [GJ]:Mob1 complex using co-immunoprecipitation 
(Figure 2.3A). I plan to repeat co-immunoprecipitation of 635 [GJ] and Mob1 from cell 
lysate using more sensitive detection methods to determine whether 635 [GJ] and Mob1 
form a protein:protein complex as suggested by the results from the luciferase reporter 
assay and the detection of substrate phosphorylation analyzed by Western blot. 






The molecular role of Mob1 in the activation of Lats1 kinase 
 
Introduction  
Mob1 in the Hippo signaling pathway interacts with both kinases of the Hippo 
pathway core kinase cassette. Mob1 is phosphorylated by Mst1/2 kinase (Praskova et al., 
2008). Multiple studies have demonstrated that phosphorylation of Mst1/2 enhances 
Mob1 binding to Lats1/2 kinase (Ni et al., 2015; Xiong et al., 2017). When Mob1 binds 
Lats1/2 kinase, both Lats1/2 autophosphorylation and substrate phosphorylation are 
stimulated (Bothos et al., 2005). Thus, the role of Mob1 in Hippo signaling is crucial as 
Mob1 stimulates Lats1/2 kinase activity resulting in phosphorylation of YAP, the 
downstream target of the Hippo tumor suppressor pathway (Hao et al., 2008). Here, we 
aim to elucidate the molecular role of Mob1 in the activation of Lats1 kinase. 
Mob1 is comprised of two unique domains. The core domain is comprised of nine 
-helices and two -strands. The N-terminal extension (NTE) is a flexible region that 
associates with the core domain. The crystal structure of full-length, unphosphorylated 
Mob1 demonstrates two components that stabilize the interaction between the NTE and 
core domain (Kim et al., 2016) (Figure 3.1). First, a 4-turn -helix in the NTE binds the 
core domain through electrostatic and hydrophobic interactions. Second, a -strand in the 




Upon phosphorylation, the NTE undergoes a conformational change as revealed 
by comparing the structures of full-length, unphosphorylated Mob1 and phosphorylated 
Mob1 bound to Lats1 MBD (Ni et al., 2015; Kim et al., 2016) (Figure 3.1). Mst2 
phosphorylates two residues in the NTE, T12 and T35 (Praskova et al., 2008). T35 lies at 
the C-terminal end of the NTE 4-turn -helix within a hydrophobic patch of the Mob1 
core domain. Phosphorylation of T35 results in electrostatic repulsion and steric clash 
that contributes to the conformational change of the NTE – loss of partial helicity and the 
-helix shifting away from the Mob1 core domain. Phosphorylated T12 can now occupy 
a phosphopeptide binding pocket comprised of basic amino acid residues within the 
Mob1 core domain. The movement of the NTE results in a shift of the -sheet formed by 
the NTE and Mob1 core domain.  
Three key domains comprise Mst2 kinase: a kinase domain and C-terminal 
SARAH dimerization domain that are connected by a long-flexible linker domain. 
Dimerization of Mst2 results in autophosphorylation of the activation loop within the 
kinase domain and subsequent autophosphorylation of various serine/threonine residues 
in the linker domain (Ni et al., 2013). Ni et al. demonstrated that Mob1 binds the 
phosphorylated linker domain of Mst2 as depicted by a crystal structure of 
unphosphorylated Mob1 bound to a phosphorylated Mst2 (pMst2) peptide (Figure 3.1) 
(Ni et al., 2015).  
Phosphorylation induced conformational changes in Mob1 destabilize complex 
formation between Mob1 and pMst2 (Ni et al., 2015). First, pT12 of Mob1 and the 
phosphorylated residues of the Mst2 linker compete for the same phosphopeptide binding 
pocket within the Mob1 core domain. Second, both the NTE and pMst2 linker domain 
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associates with the same -strand of the Mob1 core domain. pMob1 has lower binding 
affinity to pMst2 than unphosphorylated Mob1 that suggests phosphorylation induced 
conformational changes in Mob1 mediates release of Mob1 (Xiong et al., 2017).  
Phosphorylation of Mob1 results in a conformational change in the NTE that 
relieves a steric block of the Lats1 binding site within the Mob1 core domain (Ni et al., 
2015; Kim et al., 2016). In unphosphorylated Mob1, the 4-turn -helix within the NTE 
occupies the Lats1 binding site in the Mob1 core domain. Xiong et al. demonstrated that 
the NTE of Mob1 and Lats1 MBD compete to bind the Mob1 core domain (Xiong et al., 
2017). The importance of phosphorylation of T12 and T35 for Lats1 binding to Mob1 has 
been validated in different binding experiments completed with T12A/T35A Mob1 
mutants (Praskova et al., 2008; Ni et al., 2015; Xiong et al., 2017). Thus, both structural 
and mutational analysis confirm phosphorylation of Mob1 results in a conformational 
change in the NTE that assists Lats1-Mob1 binding.  
A recent study identified that Lats1 binding to Mob1 not only stimulate Lats1 
kinase activity but also the phosphorylation of Lats1 by Mst2 (Ni et al., 2015). Hoa et al. 
observed that interrupting the Lats2-Mob1 binding interaction inhibits phosphorylation of 
Lats2 hydrophobic motif (Hoa et al., 2016). Ni et al. hypothesized that Mob1 mediates 
the recruitment of Mst2 and Lats1 resulting in stimulation of Lats1 hydrophobic motif 
phosphorylation because the pMst2 and Lats1 binding sites within the Mob1 core domain 
do not intersect. They isolated a ternary complex between Lats1 MBD, pMst2, and 
unphosphorylated Mob1 in vitro using gel filtration chromatography (Ni et al., 2015).  
Although the structures of Mob1, mutational analysis, and reported binding 








Cloning Lats1 Mob1 binding domain 
Residues 635-698 of Lats1 were cloned into a pSat-L vector downstream of a 
hexahistidine and SUMO tag using LIC cloning that was confirmed by DNA sequencing. 
 
Purification of Lats1 Mob1 binding domain 
Transformed T7 Express cells (New England BioLabs) were grown in 8L of TB media at 
37 . Cells were induced using 0.5mM IPTG at 1.7 OD600. Following induction, cells 
were grown at 37  for three hours.  
 
Cells were resuspended in 150mL lysis buffer (50mM Tris pH 8.0, 800mM NaCl, and 
10% glycerol) supplemented with protease inhibitor cocktail (Sigma-Aldrich). Cells were 
lysed using the micro-fluidizer. Lysate was clarified by centrifugation at 23,000rpm at 
4  for 30 minutes. 5mM ATP and 10mM MgCl2 was added to supernatant. Supernatant 
was loaded onto 10mL column volume (CV) of Profinity-IMAC resin (Bio-Rad) and 
incubated for 1 hour at 4  Resin was collected by centrifugation at 1000rpm for 5 
minutes at 4 Resin was washed in batch twice with 5CV of lysis buffer and three times 
with 5CV of lysis buffer supplemented with 10mM Imidazole. Lats1 MBD was eluted in 
50mM Tris pH 8.0, 100mM NaCl, 5% glycerol, 5mM ATP, 10mM MgCl2, and 125mM 
Imidazole. Lats1 MBD was incubated in 1:10 SENP (ratio of concentration of protein) 
for 1 hour at room temperature (Malakhov et al., 2004). Lats1 MBD was diluted with 
20mM Tris pH 8.0 and 5% glycerol to lower the concentration of NaCl to 50mM and 
loaded onto a 5mL CV Hi Trap SP column (GE Healthcare). Lats1 MBD was eluted 
using an increasing NaCl concentration gradient. Fractions with Lats1 MBD were pooled, 
 
 35 
and protein was clarified by centrifugation at 23,000rpm for 30 minutes at 4 . 
Supernatant was diluted with 20mM HEPES pH 8.0 and 5% glycerol to lower the NaCl 
concentration to 50mM and loaded onto a 6mL CV Resource S cation exchange 
chromatography column (GE Healthcare). Lats1 MBD was eluted using an increasing 
NaCl concentration gradient. Fractions containing Lats1 MBD were pooled, and glycerol 
was added to store Lats1 MBD in 10% glycerol. Lats1 MBD was concentrated to 








Isolating the ternary complex in vitro  
 
We aim to isolate the ternary complex in vitro using a series of pull-down 
experiments and analyze whether the phosphorylation state of Mob1 affects complex 
formation (Figure 3.3). We plan to purify Lats1 MBD, Mob1 both phosphorylated and 
unphosphorylated, and pMst2 to input in the pull-down experiment. By purifying both 
phosphorylated and unphosphorylated Mob1 for use in the pull-down experiment, we will 
be able to determine whether the phosphorylation state of Mob1 affects ternary complex 
formation.  
We referenced previously conducted binding analysis to design proper negative 
and positive controls for the pull-down experiment as the proteins within the ternary 
complex – Lats1, Mob1, and Mst2 – have binding interactions independent of the 
formation of the ternary complex. Mst2 and Mob1 as well as Mob1 and Lats1 form 
complexes (Ni et al., 2015). However, Mst2 and Lats1, when co-expressed in cells, do 
not form a complex (Chan et al., 2005). First, we will confirm the Lats1-Mob1 and 
pMst2-Mob1 binding interactions. Then, we will validate that Lats1 MBD and pMst2 do 
not form a complex in vitro. With the establishment of these controls, we plan to couple 
Lats1 MBD to resin and detect ternary complex formation by analyzing pull-down of 
pMst2. If pMst2 is detected in the pull-down experiment, it will be a result of ternary 
complex formation rather than an independent binding interaction between pMst2 and 





We isolated Lats1 MBD using affinity chromatography and cleaved the H6SUMO 
tag by adding SENP (Malakhov et al., 2004). Lats1 MBD was further purified by cation 
exchange chromatography. During purification, monitoring absorbance at 280nm is not 
useful for Lats1 MBD as it does not contain any tryptophans. Chromatograms therefore 
better report on the presence of contaminants. During cation exchange chromatography, 
we found that the absorbance peaks were not representative of the elution peak of Lats1 
MBD as the presence of other contaminants would overwhelm the absorbance signal. 
Thus, we relied on monitoring Lats1-MBD purification using Coomassie stained SDS 
PAGE (Figure 3.5).   
Care must be taken when transferring the protein into a low salt buffer before 
loading onto the cation exchange chromatography column. When protein was diluted to 
100mM NaCl prior to loading onto the column, Lats1 MBD was present in the flow-
through and did not completely bind the cation exchange chromatography column 
(Figure 3.5). However, when protein was diluted to 50mM NaCl prior to loading onto 
the column, Lats1 MBD was not present in the flow-through fractions (Figure 3.6). 
Although higher NaCl concentrations improved solubility of Lats1 MBD in cell lysate, 
higher NaCl concentrations prevented Lats1 MBD to bind to the cation exchange 







Gel filtration chromatography was used to further isolate Lats1-MBD (Figure 
3.7). Initially, Lats1-MBD was isolated using gel filtration chromatography on a HiLoad 
16/600 Superdex 75 size exclusion column (GE Healthcare) equilibrated in 20mM Tris 
pH 8.0, 100mM NaCl, and 5% glycerol. However, Lats1 MBD did not elute at the 
predicted volume. In fact, Lats1 MBD eluted after the entire volume of the column. We 
hypothesized that Lats1 MBD associates with the resin of the gel filtration column. Next, 
we loaded a fraction of Lats1 MBD from the initial gel filtration chromatography 
purification onto a Superdex 75 10/300GL gel filtration chromatography column 
equilibrated in 400mM NaCl to minimize any interactions between Lats1 MBD and resin. 
The elution profile of Lats1 MBD in high salt matched the predicted elution volume for a 
protein of that size.  
We decided to repeat the elution conditions in the second gel filtration 
chromatography purification to a larger-scale purification of Lats1 MBD (Figure 3.8). 
We loaded Lats1 MBD on a Hi Load 26/600 Superdex 75 size exclusion column (GE 
Healthcare) equilibrated in 400mM NaCl following IMAC and cation exchange 
chromatography purification. However, we found that Lats1 MBD interacted with the 
column again. We concluded that Lats1 MBD associates with resin of Hi Load Superdex 
gel filtration chromatography columns despite increasing NaCl concentration during 
protein elution.  
We could not use the Superdex 75 10/300GL gel filtration chromatography 
column due to volume constraints for future, large-scale purifications and decided to 
replace gel filtration chromatography with a second cation exchange chromatography 
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purification. We successfully separated Lats1 MBD from contaminants using the 









Three components comprise Lats1 kinase activation and stimulation of Lats1 
kinase activity: phosphorylation of T1079 within the hydrophobic motif by Mst2, 
autophosphorylation of S909, and binding to Mob1, a co-activator (Chan et al., 2005; 
Hergovich, Schmitz & Hemmings, 2006). Here, we aim to elucidate the molecular role of 
Mob1 in Lats1 kinase activation. We find that Mob1 co-expression with Mst2 and Lats1 
stimulates phosphorylation of Lats1 hydrophobic motif by Mst2 in concordance with 
previous studies (Ni et al., 2015; Hoa et al., 2016).  
Ni et al. hypothesized that Mob1 mediates the formation of a ternary complex 
between Lats1, pMst2, and Mob1 that results in stimulation of Lats1 phosphorylation by 
Mst2. Although the ternary complex has been observed in vitro, we aim to further 
validate that ternary complex formation mediates stimulation of Lats1 hydrophobic motif 
phosphorylation by Mst2 in HEK293 cells. We plan to interrupt both the Mob1-Mst2 and 
Mob1-Lats1 binding interactions in HEK293 cells and analyze Lats1 pT1079 
phosphorylation using Western blot analysis. Mutating the basic amino acid residues 
(R697A, R694A, R657A, R660A, and S690A) within the Lats1 MBD inhibits Mob1 
binding (Ni et al., 2015). Also, as previously mentioned, T12A/T35A Mob1 mutants also 
bind Lats1 MBD less than wt Mob1 (Praskova et al., 2008; Ni et al., 2015; Xiong et al., 
2017). The Mob1 and Mst2 binding interaction is also inhibited with mutations of the 
basic amino acid residues (K153A, R154A, and R157A) that comprise the 
phosphopeptide binding pocket within the Mob1 core domain (Couzen et al., 2017). We 
will confirm that the mutations disrupt only the binding interaction of interest using co-
immunoprecipitation in HEK293 cells. If the ternary complex is necessary to stimulate 
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phosphorylation of Lats1 hydrophobic motif by Mst2, disrupting one of the binding 
interactions within the ternary complex will inhibit the stimulation of phosphorylation of 
Lats1 hydrophobic motif by Mst2 caused by Mob1 co-expression. 
Ni et al. isolated the ternary complex between Lats1 MBD, pMst2, and 
unphosphorylated Mob1 in vitro using gel filtration chromatography (Ni et al., 2015). 
However, they did not address whether the phosphorylation state of Mob1 may affect 
formation of the ternary complex. As previously stated, the NTE when unphosphorylated 
occupies the Lats1 binding site (Ni et al., 2015; Kim et al., 2016). On the other hand, 
when the Mob1 NTE is phosphorylated, it occupies the phospho-peptide binding pocket 
and forms a -sheet with the Mob1 core domain - phosphorylated Mob1 NTE competes 
with the phosphorylated Mst2 linker domain to bind the same sites in the Mob1 core 
domain (Ni et al., 2015). We plan to isolate the ternary complex in vitro and answer 
whether the phosphorylation state of Mob1 affects ternary complex formation using a 
series of pull-down experiments. I plan to purify both phosphorylated Mob1, 
unphosphorylated Mob1, pMst2, and Lats1 MBD for use in the pull-down assay. Thus 
far, I have purified Lats1 MBD and developed a robust protocol for the expression and 
purification of Lats1 MBD.  
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Protein-protein interactions play a crucial role in many signaling pathways. In the 
Hippo tumor suppressor pathway, complex formation between Lats1 and Mob1 increases 
Lats1 kinase activity (Hergovich et al., 2006). Co-immunoprecipitation assays are used to 
isolate and identify protein complexes. The co-immunoprecipitation assay is a useful 
biochemical tool to map the binding interface of protein-protein interactions. 
In co-immunoprecipitation, the protein of interest is isolated from cell lysate as a 
result of the protein being recognized by a specific antibody, and the antibody isolated by 
interactions with Protein G resin. Antibodies that recognize an epitope on the protein of 
interest are not always readily available, so often the protein of interest is expressed as an 
epitope-tagged fusion using tags such as Myc, HA, and FLAG tag that are recognized by 
commercially available antibodies. Following expression, lysate of cells expressing the 
epitope-tagged protein is mixed with the appropriate antibody. The antibody will bind the 
epitope-tagged protein (“bait”) and when the protein:antibody complex is isolated any 
proteins that bind directly or indirectly to the protein of interest (“prey”) will also be part 
of the antibody complex. The antibody-bound protein complex will be referred to as the 
"immunocomplex" (Figure 4.1). Immobilized Protein G resin is commonly used to 
precipitate the immunocomplex from solution. Protein G is a protein of the cell wall of 
group G streptococci that binds the Fc region of many subtypes of immunoglobulin G 




complex was used as the model system for developing the co-immunoprecipitation assay 
because the protein complex had been purified and detected in vitro (Hergovich et al., 





immunoprecipitation reaction. The reaction was conducted for 3 hours at 4 . Resin was 
isolated by centrifugation at 1000g for 3 minutes, and supernatant was aspirated. Protein 
G resin was washed in batch 6 times with 1mL ice-cold IP buffer supplemented with 
50mM NaF, 1mM Na3VO4, and 0.5mM PMSF. Proteins were eluted from Protein G 
resin by boiling for 5 minutes in 50µl 2.5X sodium dodecyl sulfate (SDS) gel agent. 
Samples were analyzed by Western blot. 
 
Western blot analysis  
In order to detect HA-Mob1 and Myc-Lats1, samples were resolved on 10 or 15% 
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred 
to nitrocellulose membranes (0.45 m) using the Trans-Blot Turbo Transfer System (Bio-
Rad). Membranes were blocked in 5% skimmed milk powder in Tris-buffered saline 
(TBS: 20mM Tris pH 7.6 and 150mM NaCl) for 30 minutes at room temperature. 
Membranes were probed with either -HA or -Myc antibodies overnight at 4  (Table 
4.2). Membranes were washed three times with TBS-T (20mM Tris pH 7.6, 150mM 
NaCl, 0.1% Tween 20) for 5 minutes. Then, membranes were incubated with 
fluorophore-conjugated secondary antibodies for 1 hour at room temperature (Table 4.2). 
The membranes were washed three times with TBS-T for 5 minutes. Blots were scanned 
on an Odyssey Infrared Imaging System (LI-COR) and analyzed using ImageStudio 







Selection of lysis buffer to maintain binding interaction 
We tested different lysis buffers to determine how the binding interactions 
between Lats1 and Mob1 could be best preserved and Lats1 and Mob1 isolated as a 
protein:protein complex using co-immunoprecipitation. Initially, cells were lysed using 
RIPA buffer (25mM Tris pH 7.6, 150mM NaCl, 1% NP-40, 1% sodium deoxycholate, 
and 0.1% SDS) supplemented with 1mM Na3VO4 and 1mM PMSF. Under these 
conditions, Myc-Lats1 did not co-immunoprecipitate with HA-Mob1 (Figure 4.2). The 
detergents in RIPA buffer may have destabilized complex formation as ionic detergents 
can disrupt non-covalent bonds and alter the conformation of proteins. Instead, we 
screened a gentler version of the lysis buffer. IP buffer (20mM Tris pH 8.0, 150mM 
NaCl, 1% Nonidet P-40 (NP-40), and 10% glycerol) was substituted for RIPA to lyse the 
cells. IP buffer contains NP-40, a nonionic detergent that does not alter the conformation 
of proteins and glycerol that can help stabilize protein complexes in vitro (Johnson, 
2013). When IP buffer was used to lyse the cells, Myc-Lats1 co-immunoprecipitated with 





Improving efficiency of Lats1-Mob1 isolation  
 
We wanted to determine what variables could be changed to increase capture and 
improve detection of the protein complex. For this model system, it was difficult to detect 
HA-Mob1 and Myc-Lats1 using co-immunoprecipitation (Figure 4.4). This result could 
arise from multiple factors including low abundance of Myc-Lats1 or weak binding 
interaction between the proteins.  
First, the amount of total cell lysate that was loaded to Protein G resin was 
changed to see if increasing the abundance of Myc-Lats1 and HA-Mob1 could increase 
the likelihood of capture of protein:protein complex from cell lysate. Either 0.15mg or 
0.5mg of total protein in cell lysate was loaded. Increasing the total amount of cell lysate 
did not increase capture of Myc-Lats1 (Figure 4.4).  
Next, we increased the amount of antibody incubated in the immunoprecipitation 
reaction to increase the amount of protein complex that could be isolated and the 
likelihood of capture of protein:protein complex. Cell lysate was incubated with either 
0.2µg or 2µg of -HA antibody. Unfortunately, increasing the amount of -HA antibody 
used for immunoprecipitation did not increase capture of Myc-Lats1 (Figure 4.4). On the 
other hand, when both variables were increased - 2µg of -HA antibody and 0.5mg of 







Co-immunoprecipitation protocols must be optimized for different protein:protein 
complexes as the strength and nature of each varies. The experiments described here 
establish a co-immunoprecipitation protocol for use in the Kavran Lab. Three variables 
were analyzed to optimize the co-immunoprecipitation protocol: selection of lysis buffer, 
wash condition to remove non-specific binding interactions, and capture of protein 
complex.  
It is critical to select a lysis buffer that will not destabilize protein complexes. In 
these experiments, use of IP buffer results in capture of Myc-Lats1 and HA-Mob1 as a 
protein complex while use of RIPA buffer does not (Figure 4.2). Use of IP buffer better 
preserves the native conformation of proteins and binding interactions within 
protein:protein complexes due to the use of nonionic detergents. 
Proper negative controls must be included for each co-immunoprecipitation 
experiment to demonstrate that the prey protein does not interact non-specifically with 
either the antibody or resin used in immunoprecipitation. When met, this control ensures 
that if any co-immunoprecipitation of the prey protein is detected in later experiments, it 
is a consequence of interaction between the bait and prey. Here, wash conditions affect 
non-specific interactions between HA-Mob1 and Protein G resin. Increasing the volume – 
500µl to 1mL of buffer – and the number of washes – 3 washes to 6 washes – is sufficient 
to eliminate non-specific interaction between Protein G resin and HA-Mob1 (Figure 
4.3A). However, care must be taken to ensure that the stringency of the wash conditions 
not disrupt protein:protein interactions. 
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Although two proteins may form a complex, the abundance of the protein of 
interest affects detection following co-immunoprecipitation. The likelihood of capturing 
Myc-Lats1 and HA-Mob1 as a protein complex increased by increasing the amount of 
antibody used for immunoprecipitation and the amount of total cell lysate present in 
solution (Figure 4.4). I find it optimal to use 0.5mg of total protein cell lysate and 1 g of 
antibody for capture of Lats1 and Mob1 as a protein:protein complex. For other 
protein:protein complexes, the abundance of each protein may vary, and these variables 




Purification of Protein G’ for use in co-immunoprecipitation 
Introduction  
Co-immunoprecipitation assays are a standard technique used to isolate protein 
complexes from cell lysate and are commonly used in the Kavran Lab. In this assay, an 
antibody binds the protein of interest, and the complex is isolated by immobilized Protein 
G' resin. We wanted to develop a protocol to express and purify our own immobilized 
Protein G’ resin as Protein G’ resin is expensive (Table 5.1).  
Protein G is used for immunoprecipitation (IP) assays because of its specificity 
and affinity to immunoglobulin G (IgG). In nature, Protein G is a component of the cell 
wall of group G streptococci. Protein G has been applied for use in biochemical studies 
because it binds to the Fc region of immunoglobulin as well as many subtypes of IgG in 
the C-terminal region of Protein G (Eliasson et al., 1991). However, Protein G cannot 
bind IgM, IgD, or IgA (Bjorck & Kronvall, 1984). Commercially available Protein G 
resins use a modified variant (Protein G') in which the N-terminal region is truncated to 
prevent binding to human serum albumin. Thus, the use of recombinant Protein G’ in co-
immunoprecipitation ensures binding to only IgG.  
Here, we aim to develop a protocol to make an immobilized Protein G’ resin for 
use in IP assays. We first determined suitable expression and purification conditions for 
Protein G’. We asked whether our Protein G’ coupled to resin captures protein:protein 
interactions with the same efficiency as commercial resin using co-immunoprecipitation. 







Materials and Methods  
 
Cloning and expression of Protein G' 
A codon optimized gene encoding streptococcal Protein G' for expression in E.coli was 
ordered from GeneArt (Table 5.2). The gene was cloned into either a pSAT-L vector 
downstream from a hexahistidine and SUMO tag (H6SUMO) or p2AT vector without a 
tag. Both H6SUMO-Protein G’ and untagged Protein G’ were expressed in T7 Express 
cells (New England BioLabs), and growth and induction methods were the same for both 
expressions. Transformed T7 Express cells grew at 37°C in LB media. Protein expression 
was induced at 0.5 OD600 with 0.5mM IPTG and harvested after 3 hours. 
 
Purification of H6SUMO-Protein G’ (pSAT-L vector) 
Cells grown in 1L of LB media were lysed in 50mL of lysis buffer (50mM Tris pH 8.0, 
400mM NaCl, and 5% glycerol) supplemented with protease inhibitor cocktail (Sigma-
Aldrich) using the micro-fluidizer. Cell lysate was clarified by centrifugation at 
23,000rpm for 30 minutes at 4° . Supernatant was incubated with 5mL column volume 
(CV) of Profinity-IMAC resin (Bio-Rad) for 1 hour, rotating, at 4°C. Resin was collected 
by centrifugation at 1000g for 5 minutes at 4° , and supernatant aspirated. Resin was 
washed in batch twice with 5CV of lysis buffer and three times with 5CV of lysis buffer 
supplemented with 10mM Imidazole. Protein G' was eluted with 50mM Tris pH 8.0, 
400mM NaCl, 5% glycerol, and 125mM Imidazole. Protein was dialyzed into 20mM Tris 
pH 7.0, 100mM NaCl, 5% glycerol, in the presence of 0.17µM SUMO-specific protease 
(SENP) for cleavage of the H6SUMO tag at 4°  overnight (Malakhov et al., 2004). 
Following dialysis, protein was clarified by centrifugation at 23,000rpm for 30 minutes at 
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4° . The supernatant was diluted with 10mM Tris pH 8.0 to lower the concentration of 
NaCl to 50mM and loaded onto a 5mL CV Hi Trap Q HP column (GE Healthcare). 
Protein was eluted with an increasing concentration gradient of NaCl. Fractions 
containing Protein G' were pooled and loaded on a HiLoad 16/600 Superdex 75 size 
exclusion column (GE Healthcare) equilibrated in 10mM HEPES pH 7.5 and 200mM 
NaCl.  Fractions containing Protein G' were concentrated to 25mg/mL and flash frozen in 
liquid nitrogen. 
 
Purification of untagged Protein G' (p2AT vector) 
Cells grown in 4L of LB Media were lysed in 100mL of lysis buffer supplemented with 
protease inhibitor cocktail (Sigma-Aldrich) using the micro-fluidizer. Lysate was 
clarified by centrifugation at 23,000rpm for 30 minutes at 4° . Supernatant was diluted 
with sufficient volume of 10mM Tris pH 8.0 to reduce the final concentration of NaCl to 
50mM and loaded onto a 5mL Hi Trap Q HP anion exchange column. Protein G' was 
eluted using an increasing concentration gradient of NaCl. Fractions containing Protein 
G' were pooled and loaded on a HiLoad 26/600 Superdex 75 size exclusion column (GE 
Healthcare) equilibrated in 10mM HEPES pH 7.5 and 200mM NaCl. Fractions 
containing Protein G' were concentrated to 6.9mg/mL and flash frozen in liquid nitrogen. 
 
Coupling Protein G' to resin 
Profinity Epoxide Resin (Bio-Rad) coupling reaction  
Resin was swelled in 10CV of water rotating for 30 minutes at room temperature (1g of 
resin swells to 8mL CV). Resin was collected by centrifugation at 1000g for 5 minutes at 
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4° , and supernatant aspirated. Purified Protein G' was diluted using 100mM NaHCO3 
pH 11.3 to a final volume of 2CV of swelled resin and added to resin (2mg Protein G' per 
1mL CV of swelled resin). Resin and protein were incubated for 10 minutes at room 
temperature while gently rocking. 800mg of AmSO4 per 1mL CV of swelled resin was 
added to the coupling reaction, which was then left overnight at room temperature with 
gentle rocking. The concentration of protein present before and after the coupling 
reaction was measured to monitor completion of the reaction. When the reaction was 
complete, resin was collected by centrifugation at 1000g for 5 minutes at 4° , and 
supernatant was aspirated. 10CV of 1M ethanolamine pH 8.0 was added to the resin and 
the slurry incubated for 4 hours at room temperature with gentle rocking. Resin was 
collected by centrifugation at 1000g for 5 minutes at 4° , and supernatant was aspirated. 
Resin was washed three times in batch with 5CV of 20mM Tris pH 8.0 and 200mM 
NaCl. Resin was stored in 20mM Tris pH 8.0, 200mM NaCl, and 0.1% NaN3 as a 10% 
slurry at 4° .  
 
CnBr-Activated Sepharose 4 Fast Flow (GE Healthcare) coupling reaction  
Resin was swelled in 10CV of 1mM HCl for 30 minutes at 4°C while gently rocking (1g 
of resin swells to 5mL CV). Resin was collected by centrifugation at 1000g for 5 minutes 
at 4° , and supernatant aspirated. Resin was washed in batch three times with 5CV of 
1mM HCl and once with 5CV of 10mM HEPES pH 7.5 and 200mM NaCl. Protein was 
diluted using 10mM HEPES pH 7.5 and 200mM NaCl to a final volume of 2CV of 
swelled resin and added to resin (2mg of Protein G' per 1mL CV of resin). The coupling 






Small-scale expression and solubility tests of Protein G’ 
Small-scale expression tests were performed to determine the best conditions for 
both H6SUMO-Protein G’ and untagged Protein G’ expression and solubility. Proteins 
were expressed in a BL21 strain of E.coli and grown in LB media. Protein expression 
was induced with IPTG when the cells entered mid-log, and cells grew at either 37°C for 
3 hours or 20°C overnight following induction. Samples of cell lysate taken before 
induction and at the time of harvest were resolved using Coomassie stained SDS-Page to 
determine expression of both H6SUMO-Protein G’ and untagged Protein G’ (Figure 5.1). 
There was no difference in expression for either H6SUMO-Protein G' or untagged Protein 
G' under both growth conditions. Samples of cell lysate and supernatant following 
clarification of cell lysate were analyzed using Coomassie stained SDS Page to determine 
both H6SUMO-Protein G’ and untagged Protein G’ solubility. Solubility of H6SUMO-
Protein G' appeared to be slightly improved when cells were grown at 37°C for 3 hours 
following induction (Figure 5.1A). Solubility of untagged Protein G' did not differ 
(Figure 5.1B). The optimal condition for expression and solubility of both H6SUMO-





Purification of H6SUMO-Protein G' 
We tried to purify both H6SUMO-Protein G’ and untagged Protein G’ to 
determine the easiest purification scheme of Protein G’ with high yield and purity. 
Different methods were used to purify H6SUMO-Protein G' and untagged Protein G'. We 
first isolated H6SUMO-Protein G’ using IMAC (Figure 5.2A). H6SUMO-Protein G' was 
present in the flow-through that indicated two possible scenarios: there was insufficient 
resin to bind all of H6SUMO-Protein G' present in cell lysate or H6SUMO-Protein G' 
aggregated resulting in an inability of the affinity tag to bind the Profinity-IMAC resin. 
The flow-through was loaded onto a small-scale affinity purification to determine if the 
unbound H6SUMO-Protein G' was capable of binding nickel resin (Figure 5.2B). On the 
second round of affinity purification, H6SUMO-Protein G’ bound and eluted from resin 
indicating that there was insufficient resin in the first affinity purification step to capture 
all H6SUMO-Protein G' present in cell lysate. We thus determined H6SUMO-Protein G’ 




The next step in purification is cleavage of the affinity tag from Protein G’. IMAC 
elution fractions containing H6SUMO-Protein G’ were pooled and incubated with SENP 
during dialysis. Efficient cleavage of the affinity tag is demonstrated in Figure 5.3.  
We used anion exchange chromatography followed by gel filtration 
chromatography to separate the affinity tag from untagged Protein G’. The peaks 
containing either the tag or Protein G’ partially overlapped; three of the four fractions of 
the Protein G’ peak did not contain H6SUMO, but one of the fractions had some tag 
present (Figure 5.3). All four fractions were pooled and loaded onto gel filtration 
chromatography, which separated the affinity tag from Protein G’ (Figure 5.4). The final 






Purification of Protein G’ expressed as untagged protein  
We tried to purify an untagged variant of Protein G’ to avoid the challenges 
associated with tag cleavage and separation. However, we were concerned as to how 
efficiently Protein G’ could be isolated. Untagged Protein G’ was expressed as described 
above and clarified cell lysate was loaded directly onto the anion exchange column 
(Figure 5.5). Protein G’ eluted at a lower conductivity than Protein G’ expressed as 
H6SUMO-Protein G' and was only 55% pure. Capture of Protein G’ was inefficient, as 
evidenced by presence of Protein G’ in the flow-through and wash fractions indicating 
that the column volume was insufficient to capture all of the Protein G’ from cell lysate 
(Figure 5.5). The fractions containing Protein G’ were pooled and loaded onto a gel 
filtration column. Peak fractions were collected and concentrated (Figure 5.6). The final 





Testing the efficiency of purified Protein G’ coupled to resin in co-
immunoprecipitation  
Next, we wanted to determine whether our recombinant Protein G’ when coupled 
to resin had the same efficiency as commercial Protein G’ resin in co-
immunoprecipitation. Purified Protein G' was coupled to two resins - Profinity Epoxide 
resin (Bio-Rad) and CnBr-activated Sepharose 4 Fast Flow (GE Healthcare) - to analyze 
whether different coupling chemistry and resins could affect the use of recombinant 
Protein G’ in co-immunoprecipitation (Figure 5.7). Then, the efficiency of the resin was 
measured by two criteria – the coupled resin needed to have the same non-specific 
binding pattern and the same ability to immunoprecipitate a protein:protein complex as 
commercial Protein G’ resin.  
First, Protein G’ resin was incubated with lysate of HEK293 cells transiently 
transfected with HA-Mst2 and FLAG-Mob1 in the absence of antibody to examine 
whether the resin would interact nonspecifically with either protein of interest (Figure 
5.7). Protein G’ coupled to CnBr-Activated Sepharose 4 Fast Flow resin bound HA-
Mob1 non-specifically. Nonspecific interactions between Protein G’ coupled to Profinity 
Epoxide resin with FLAG-Mob1 and HA-Mst2 was comparable to that of commercial 
Protein G’ resin.   
Next, Mst2:Mob1 protein:protein complex was immunoprecipitated from lysate 
of HEK293 cells transiently transfected with HA-Mst2 and FLAG-Mob1 to determine 
whether recombinant Protein G’ coupled to resin captures protein:protein complex 
similar to commercial Protein G’ resin (Figure 5.7). Purified Protein G’ coupled to 
CnBr-Activated Sepharose 4 Fast Flow resin captured less of the protein complex of 
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interest as compared to Protein G’ coupled to Profinity Epoxide resin or commercially 
available resin. Protein G' coupled to Profinity Epoxide resin demonstrated similar 





Protein G has been applied for use in immunoprecipitation as it can bind the Fc 
region of both monoclonal and polyclonal IgG (Eliasson et al., 1991). In the experiments 
described here, we determined protocols for the purification of two variants of Protein G’ 
– one for H6SUMO-Protein G' and the other for untagged Protein G’. We also validated 
that purified recombinant Protein G’ can be coupled to resin and used in 
immunoprecipitation as efficiently as commercial Protein G’ resin.  
Purification of H6SUMO-Protein G' requires additional steps in comparison to the 
purification of untagged Protein G': cleavage and removal of the affinity tag. Our initial 
purification of tagged Protein G’ suffered from poor capture resulting from insufficient 
IMAC resin. Thus, the yields from this purification are not indicative of those expected 
from future purifications. I estimate that the yield could be improved 3X fold if the CV 
were increased to 15ml/L of cells to ensure full capture of the protein (Figure 5.2). Anion 
exchange and gel filtration chromatography result in complete separation of H6SUMO 
and Protein G’ (Figure 5.3, 5.4). Purification of untagged Protein G’ also suffered from 
poor capture from the initial lysate, and future preps would require using 10mL CV of Hi 
Trap Q Column per 4L of cells. Overloading of the column also resulted in premature 
elution of Protein G’ causing, possibly, co-elution with contaminating proteins (Figure 
5.5).  
We decided to purify untagged Protein G’ to make our resin. First, the yield of 
Protein G’ expressed as untagged protein was significantly higher than that of Protein G’ 
expressed with the affinity tag. Second, for future purifications, we can increase the 
column volume during anion exchange chromatography to decrease contaminants present 
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by preventing premature elution of Protein G’. Last, the purification of Protein G’ 
expressed as untagged protein is significantly less time-consuming than of Protein G’ 
expressed with the affinity tag. Ultimately, we can resolve the initial concern of isolation 
of untagged Protein G’ from cell lysate while maximizing yield and minimizing the 
difficulty of purification.  
Purified Protein G’ can be coupled to resin for use in co-immunoprecipitation. 
Here, we screened two different coupling chemistry and bead types (Profinity Epoxide 
and CnBr-Activated Sepharose 4 Fast Flow) and found Protein G’ coupled to Profinity 
Epoxide resin performed similarly to commercial resin in side-by-side comparisons that 
evaluated both non-specific binding and capture efficiency (Figure 5.7). Thus, it is 







 We conducted a series of experiments for co-immunoprecipitation protocol 
optimization. The variables tested – selection of lysis buffer, capture of protein complex, 
and preventing non-specific interactions – are a good starting point to reference for 
protocol optimization. Here, co-immunoprecipitation was used to study the binding 
interactions between protein:protein complexes. Furthermore, the tools and methods 
learned from the purification of Protein G’ for use in co-immunoprecipitation were 
applied for the purification of Lats1 MBD and will be applied for purifying Mob1 and 
Mst2 for the analysis of ternary complex formation (Lats1-Mob1-Mst2) in vitro.  
This study aims to elucidate the molecular mechanism for Lats1 kinase further. 
We focused on analyzing Lats1 kinase activation from two perspectives. First, we 
identified regions of the Lats1 N and C termini that are necessary for Lats1 function to 
define a minimal, functional unit of Lats1 kinase to express and purify in vitro for future 
biochemical and structural assays. We examined Lats1 kinase function using two criteria 
thus far: binding to Mob1, a co-activator, and kinase activity analyzed by downstream 
pathway function and substrate phosphorylation. Going forward, we plan to test whether 
the N-terminal truncated Lats1 variant 635 [GJ] can bind Mob1 using more sensitive 
detection methods following co-immunoprecipitation.  
Due to time restraints, we were unable to examine the third criteria for Lats1 
kinase activation: phosphorylation of the hydrophobic motif by Mst2 and 
autophosphorylation of the activation loop. We plan to compare phosphorylation of these 
two residues between the Lats1 truncated variants and wt Lats1 using Western blot 
analysis. Once we have validated the function of the minimal units of the N and C-
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termini of Lats1, we will clone the minimal, functional unit of Lats1. We will purify the 
minimal, functional unit of Lats1 to both study the kinase activity of Lats1 in vitro and 
resolve the structure of the Lats1 variant bound to Mob1. 
Second, we examined the molecular role of Mob1 in Lats1 kinase activation. 
Recent studies have shown that not only does Mob1 binding to Lats1 enhance both 
substrate phosphorylation and autophosphorylation, but Mob1 also stimulates 
phosphorylation of Lats1 by Mst2 (Ni et al., 2015). We validated this result by transiently 
transfecting HEK293 cells with Mst2, Lats1, and Mob1 and detecting T1079 
phosphorylation by Western blot analysis. Mob1 co-expression stimulated T1079 
phosphorylation within the hydrophobic motif. Ni et al. hypothesized that Mob1 mediates 
the formation of a ternary complex to stimulate hydrophobic motif phosphorylation by 
Mst2 as the binding sites for Mst2 and Lats1 within the Mob1 core domain do not 
intersect (Ni et al., 2015).  
Although the ternary complex has been isolated in vitro using gel filtration 
chromatography, we still have many questions concerning the role of Mob1 in the 
activation of Lats1 kinase (Ni et al., 2015). We seek to answer whether the 
phosphorylation state of Mob1 affects ternary complex formation as phosphorylation 
results in Mob1 conformational change. Thus far, we have purified the Lats1 MBD and 
designed experiments to conduct pull-down experiments in vitro. We plan to purify 
phosphorylated and unphosphorylated Mob1 as well as Mst2 for use in the pull-down 
experiment. Also, we will inhibit the binding interactions within the ternary complex by 
expressing mutants of Lats1, Mst2, and Mob1 in HEK293 cells to observe how disruption 
of ternary complex formation affects phosphorylation of Lats1 by Mst2. With these 
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results, we will be able to validate whether ternary complex formation mediates the 
stimulation of Lats1 phosphorylation by Mst2 observed with Mob1 co-expression. Due to 
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